Medline ® Abstract for Reference 121
of 'Evaluation and management of drug-resistant epilepsy'
121
TI
Transcranial magnetic stimulation for the treatment of seizures: a controlled study.
AU
Theodore WH, Hunter K, Chen R, Vega-Bermudez F, Boroojerdi B, Reeves-Tyer P, Werhahn K, Kelley KR, Cohen L
SO
Neurology. 2002;59(4):560.
OBJECTIVE:
To perform a controlled trial of transcranial magnetic stimulation (TMS).
METHODS:
Twenty-four patients with localization-related epilepsy were randomized to blinded active or placebo stimulation. Weekly seizure frequency was compared for 8 weeks before and after 1 week of 1-Hz TMS for 15 minutes twice daily.
RESULTS:
When the 8-week baseline and post-stimulation periods were compared, active patients had a mean seizure frequency reduction of 0.045 +/- 0.13 and sham-stimulated control subjects -0.004 +/- 0.20. Over 2 weeks, actively treated patients had a mean reduction in weekly seizure frequency of 0.16 +/- 0.18 and sham-stimulated control subjects 0.01 +/- 0.24. Neither difference was significant.
CONCLUSION:
The effect of TMS on seizure frequency was mild and short lived.
AD
Clinical Epilepsy, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. theodorw@ninds.nih.gov
PMID